A. Aleksankin

Effect of rituximab on the manifestations of activity and pulmonary function in patients with systemic sclerosis: one-year follow-up evaluation

E. Nasonov, S. Glukhova, A. Volkov, 2019, Rheumatology Science and Practice.

Anti-topoisomerase 1 Antibody Level Changes after B Cell Depletion Therapy in Systemic Sclerosis

M. Cherkasova, L. Ananyeva, E. Nasonov, 2022, Doklady Biochemistry and Biophysics.

Adipocytes in the Uterine Wall during Experimental Healing and in Cesarean Scars during Pregnancy

L. Mikhaleva, A. Aleksankin, V. Aleksankina, 2023, International journal of molecular sciences.

The role of NETosis in the pathogenesis of immunoinflammatory rheumatic diseases

A. Avdeeva, E. Nasonov, Y. Rubtsov, 2023, Rheumatology Science and Practice.

Rituximab Downregulates Gene Expression Associated with Cell Proliferation, Survival, and Proteolysis in the Peripheral Blood from Rheumatoid Arthritis Patients: A Link between High Baseline Autophagy-Related ULK1 Expression and Improved Pain Control

E. Tchetina, G. Markova, S. Makarov, 2016, Arthritis.